Related Experiment Video
Updated: Jun 5, 2025
07:38
Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
3.4K
Rosa dos Ventos Multicenter Cohort Study of Patients with Reduced or Mildly Reduced Ejection Fraction Heart Failure
Dhayn Cassi de Almeida Freitas1, Larissa Maria de Paula Rebouças da Costa1, Wilson Nadruz2
1Universidade Federal do Acre, Rio Branco, AC - Brasil.
Arquivos Brasileiros De Cardiologia
|December 4, 2024
Summary
The Rosa dos Ventos study is characterizing heart failure (HF) in Brazil, revealing regional differences and prognosis. This research provides crucial data for developing effective HF management strategies nationwide.
Area of Science:
- Cardiology
- Public Health
Background:
- Limited data exists on regional disparities and heart failure (HF) prognosis in Brazil.
- Brazil's diverse biomes and social inequalities may influence HF prevalence and outcomes.
Purpose of the Study:
- To investigate regional variations in HF.
- To determine the current prognosis of outpatients with reduced or mildly reduced ejection fraction (HFmrEF) in Brazil.
Main Methods:
- Prospective, multicenter, observational cohort study.
- Enrollment of 2,500 outpatients aged >18 years with HF (ejection fraction <50%) across 30 Brazilian centers.
- 12-month follow-up collecting clinical, socioeconomic, and treatment data, plus emergency visits, hospitalizations, and mortality.
Main Results:
- Data collection ongoing; results pending.
- Anticipated analysis of regional differences in HF patient characteristics and outcomes.
- Expected identification of prognostic factors influencing HF progression in Brazil.
Conclusions:
- The Rosa dos Ventos study will provide a comprehensive characterization of chronic heart failure in Brazil.
- Findings will inform the development of targeted management strategies.
- This research aims to mitigate the impact of HF on patients and the healthcare system.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
385
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
2
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
2
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
102
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
102
01:17Imaging Studies for Cardiovascular System I:Echocardiography
295
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
295